News
US WorldMeds (USWM) reported the successful closing of the previously announced acquisition of Adaptimmune Therapeutics plc's (Adaptimmune) cell-therapy assets — including TECELRA® (afamitresgene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback